The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 27, 2018

Filed:

Aug. 30, 2012
Applicants:

Masad J. Damha, St. Hubert, CA;

Michael A. Parniak, Pittsburg, PA (US);

Inventors:

Masad J. Damha, St. Hubert, CA;

Michael A. Parniak, Pittsburg, PA (US);

Assignee:

MCGILL UNIVERSITY, Montreal, CA;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/02 (2006.01); C12N 15/11 (2006.01); C07H 21/04 (2006.01); C12N 15/113 (2010.01); C07H 21/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); C07H 21/00 (2013.01); A61K 38/00 (2013.01); C12N 2310/32 (2013.01); C12N 2310/321 (2013.01); C12N 2310/322 (2013.01); C12N 2310/323 (2013.01); C12N 2310/3231 (2013.01); C12N 2310/346 (2013.01);
Abstract

The invention relates to oligonucleotides having alternating segments of sugar-modified nucleosides and 2'-deoxynucleosides, and uses thereof. The invention further related to oligonucleotides having alternating segments of sugar-modified nucleotides and 2′-deoxynucleotides, and uses thereof. Such uses include the preparation of antisense oligonucleotides and their use for the prevention or depletion of function of a target nucleic acid of interest, such as an RNA, in a system. Accordingly, and oligonucleotide of the invention is useful for therapeutic, analytical and diagnostic methods and uses, as well as component of compositions and commercial packages corresponding to such methods and uses.


Find Patent Forward Citations

Loading…